ID

28332

Description

NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz

Keywords

  1. 11/30/17 11/30/17 -
  2. 1/4/18 1/4/18 -
Copyright Holder

Prof. Dr. med. Georg Heß

Uploaded on

January 4, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Screening Prior lymphoma treatment GOAL Trial B-cell Lymphoma NCT02499003

Screening Prior lymphoma treatment GOAL Trial B-cell Lymphoma NCT02499003

Admininstrative data
Description

Admininstrative data

Alias
UMLS CUI-1
C1320722
Subject ID
Description

Subject ID

Data type

text

Alias
UMLS CUI [1]
C2348585
Any prior lymphoma treatment?
Description

prior therapy lymphoma

Data type

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0024299
Prior lymphoma treatment
Description

Prior lymphoma treatment

Alias
UMLS CUI-1
C1514463
UMLS CUI-2
C0024299
No.
Description

Therapy number

Data type

integer

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0750480
Chemotherapy
Description

Chemotherapy

Data type

integer

Alias
UMLS CUI [1]
C0392920
Antibody
Description

Antibody

Data type

integer

Alias
UMLS CUI [1]
C0003241
Novel agent
Description

Agent

Data type

integer

Alias
UMLS CUI [1]
C0450442
Consolidation
Description

Consolidation

Data type

integer

Alias
UMLS CUI [1]
C3179017
No. of cycles
Description

Number of cycles

Data type

integer

Alias
UMLS CUI [1]
C2045831
Start date
Description

Start date

Data type

date

Alias
UMLS CUI [1]
C0808070
Stop date
Description

Stop date

Data type

date

Alias
UMLS CUI [1]
C0806020
Best response
Description

Best response

Data type

integer

Alias
UMLS CUI [1]
C2986560

Similar models

Screening Prior lymphoma treatment GOAL Trial B-cell Lymphoma NCT02499003

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Admininstrative data
C1320722 (UMLS CUI-1)
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
prior therapy lymphoma
Item
Any prior lymphoma treatment?
boolean
C1514463 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
Item Group
Prior lymphoma treatment
C1514463 (UMLS CUI-1)
C0024299 (UMLS CUI-2)
Therapy number
Item
No.
integer
C0087111 (UMLS CUI [1,1])
C0750480 (UMLS CUI [1,2])
Item
Chemotherapy
integer
C0392920 (UMLS CUI [1])
Code List
Chemotherapy
CL Item
2-CDA (1)
C0092801 (UMLS CUI-1)
(Comment:en)
CL Item
B-ALL-protocol (2)
(Comment:en)
CL Item
Bendamustine (3)
C0525079 (UMLS CUI-1)
(Comment:en)
CL Item
BM (4)
C0005953 (UMLS CUI-1)
(Comment:en)
CL Item
CEMP (5)
C0214287 (UMLS CUI-1)
(Comment:en)
CL Item
Chlorambucil (6)
C0008163 (UMLS CUI-1)
(Comment:en)
CL Item
CHOEP14 (7)
C0109491 (UMLS CUI-1)
(Comment:en)
CL Item
CHOEP21 (8)
C0109491 (UMLS CUI-1)
(Comment:en)
CL Item
CHOP14 (9)
C0109491 (UMLS CUI-1)
(Comment:en)
CL Item
CHOP21 (10)
C0109491 (UMLS CUI-1)
(Comment:en)
CL Item
CVP (11)
CL Item
DexaBEAM (12)
CL Item
DHAP (13)
CL Item
DHOAX (14)
CL Item
Etoposide (15)
CL Item
FC (16)
CL Item
Fludarabine (17)
CL Item
Gemcitabine (18)
CL Item
GemOx (19)
CL Item
ICE (20)
CL Item
IEV (21)
CL Item
IMVP16 (22)
CL Item
Knospe (23)
CL Item
MCP (24)
CL Item
Mega-CHOEP (25)
CL Item
Methotrexat (26)
CL Item
Pixantrone (27)
CL Item
R-DHAC (28)
CL Item
Cyclophosphamide (29)
Item
Antibody
integer
C0003241 (UMLS CUI [1])
Code List
Antibody
CL Item
Alemtuzumab (1)
C0383429 (UMLS CUI-1)
(Comment:en)
CL Item
lbritumomab (2)
C1272713 (UMLS CUI-1)
(Comment:en)
CL Item
Obinutuzumab (3)
C2742503 (UMLS CUI-1)
(Comment:en)
CL Item
Ofatumomab (4)
C1832027 (UMLS CUI-1)
(Comment:en)
CL Item
Rituximab (5)
C0393022 (UMLS CUI-1)
(Comment:en)
Item
Novel agent
integer
C0450442 (UMLS CUI [1])
Code List
Novel agent
CL Item
Bortezomib (1)
C1176309 (UMLS CUI-1)
(Comment:en)
CL Item
Everolimus (2)
C0541315 (UMLS CUI-1)
(Comment:en)
CL Item
lbrutinib (3)
C3501358 (UMLS CUI-1)
(Comment:en)
CL Item
ldelalisib (4)
C2698692 (UMLS CUI-1)
(Comment:en)
CL Item
Lenalidomid (5)
C1144149 (UMLS CUI-1)
(Comment:en)
CL Item
Temsirolimus (6)
C1707080 (UMLS CUI-1)
(Comment:en)
CL Item
Venetoclax (7)
C4079830 (UMLS CUI-1)
(Comment:en)
Item
Consolidation
integer
C3179017 (UMLS CUI [1])
Code List
Consolidation
CL Item
BEAM (1)
C0053063 (UMLS CUI-1)
(Comment:en)
CL Item
BEAC (2)
C0105125 (UMLS CUI-1)
(Comment:en)
CL Item
lbritumomab (3)
C1272713 (UMLS CUI-1)
(Comment:en)
CL Item
TBI/Cy (4)
C0547720 (UMLS CUI-1)
(Comment:en)
CL Item
Transplant: full allo (5)
C0149615 (UMLS CUI-1)
(Comment:en)
CL Item
Transplant: mini allo (6)
C0149615 (UMLS CUI-1)
(Comment:en)
CL Item
other conditioning (7)
C0205394 (UMLS CUI-1)
(Comment:en)
CL Item
Hd-BM (Carmustin/Melphalan) (8)
C0007257 (UMLS CUI-1)
(Comment:en)
Number of cycles
Item
No. of cycles
integer
C2045831 (UMLS CUI [1])
Start date
Item
Start date
date
C0808070 (UMLS CUI [1])
Stop date
Item
Stop date
date
C0806020 (UMLS CUI [1])
Item
Best response
integer
C2986560 (UMLS CUI [1])
Code List
Best response
CL Item
CR (1)
C0677874 (UMLS CUI-1)
(Comment:en)
CL Item
CRu (2)
C1275810 (UMLS CUI-1)
C1547326 (UMLS CUI-2)
(Comment:en)
CL Item
PR (3)
C1521726 (UMLS CUI-1)
(Comment:en)
CL Item
SD (4)
C0677946 (UMLS CUI-1)
(Comment:en)
CL Item
PD (5)
C1335499 (UMLS CUI-1)
(Comment:en)
CL Item
Discontinued (6)
C1444662 (UMLS CUI-1)
(Comment:en)
CL Item
Unknown (7)
C0439673 (UMLS CUI-1)
(Comment:en)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial